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Mesenchymal Stem Cell Therapy 
of Male Infertility
Amin Tamadon, Ulanbek Zhan-byrbekuly, Ilyas Kairgaliyev 
and Arezoo Khoradmehr
Abstract
Nowadays mesenchymal stem cell (MSC) therapy offers a broad spectrum of 
treatment of different conditions, including male infertility. Lots of studies sug-
gest that injection of MSC promotes differentiation of germ cells and/or stimulates 
gonadal tissue development. Currently, there are plenty of MSC therapies of 
azoospermia which have been studied on animal models and demonstrated good 
results. Most of the studies were conducted using MSC derived from adipose tissue, 
the bone marrow, and umbilical cord. Despite the fact that this type of treatment in 
humans is not established as a first choice option, the use of these techniques gives 
us hope for a gradual introduction into our daily practice.
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1. Introduction
Infertility is a disease of the reproductive system defined by the failure to 
achieve a clinical pregnancy after 12 months or more of regular unprotected sexual 
intercourse [1]. This disorder affects one in six couples [2]. Different factors includ-
ing genetics, environmental factors, and anatomical defects have been illustrated to 
play a role in the fertility ability of individuals [3, 4].
After identifying the high capability of stem cells to produce different cell 
types, a number of scientists have proposed the use of stem cells and cell-based 
therapies as a possible new therapeutic choice for male infertility [5]. Stem cells are 
undifferentiated cell types that have two main characteristics, self-renewal with 
the production of identical daughter cells, and the ability to differentiate into more 
specialized cell types. The two main non-manipulated stem cell classes are embry-
onic (ESCs) and adult stem cells (ASCs) [5]. The next type of stem cells is induced 
pluripotent stem cells (iPSCs) which are genetically manipulated somatic cells [6]. 
The experimental platform for understanding the development of germ cells could 
be provided by the in vitro generation of male germ cells from stem cells [7, 8].
The ESCs, iPSCs, and spermatogonial stem cells (SSCs) are among the most 
investigated stem cells for the production of male germ cells in in vitro conditions 
[9, 10]. Application of these cell types has some limitations. ESCs present with some 
ethical problems and their sources are limited. iPSCs have both oncological and 
genetic instabilities. SSCs have low content in the testis, and their isolation, identifi-
cation, and culturing are difficult in vitro.
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On the other hand, mesenchymal stem cells (MSCs) do not have such problems 
in applications. MSCs are a group of ASCs which are available in most tissues. These 
cells were separated from the bone marrow [11], adipose tissue [12–14], hair follicle 
[15], endometrium [16, 17], dental pulp [18], nose [19], umbilical cord [20], and 
menstrual blood [21]. The MSCs in bone marrow stromal comprise a restricted 
area; but it can be easily proliferated [22]. These cells have the potential to prolifer-
ate and differentiate into other cells such as osteoblast [23, 24], adipocyte [25], 
chondroblasts [26], and neuron-like cells [27, 28] which can be a good candidate for 
treatment of male infertility. MSCs contains heterogeneous population of cells and 
contain pluripotent stem cells, namely multilineage-differentiating stress-enduring 
cells, which is the same as ESCs, which has the ability to differentiate into all cells 
from three germ layers spontaneously [29, 30].
2. Treatment of male infertility by MSC transplantation
Several animal studies have been conducted to investigate the effect of MSC trans-
plantation on azoospermia. The effect of bone marrow-derived MSCs (BM-MSCs) 
and adipose tissue-derived MSCs (AD-MSCs) in induced azoospermia rodents was 
explored [11, 12, 24, 26, 31, 32]. After busulfan injection for azoospermia induction 
[33], the rats were injected with the MSCs into rete testes. After 2 months, testes 
treated with MSCs appeared morphologically normal. Spermatogenesis was detected, 
not in every but in some tubules of cell-treated testes. The trans-differentiation of 
MSCs into spermatogenetic cells in the appropriate microenvironment has been 
shown in some studies [32]. To demonstrate the entire recovery of spermatogenesis, 
rats, which were under cell treatment, were mated, and consequently next genera-
tions were obtained. The GFP expression was identified in the MSCs derived from the 
bone marrow and adipose tissue and in the sperm of offsprings as well [32].
Numerous in vivo research surveys have been conducted to assess the spermato-
genesis induction potential of mesenchymal stem cells in mouse and rat animal 
models. In the mentioned study groups, bone marrow-derived mesenchymal stem 
cells have been used for the induction of spermatogenesis. There are some disputes, 
in mice model, regarding advisability of bone marrow-derived mesenchymal stem 
cell transplantation in azoospermic mice, for example, there was a report that bone 
marrow-derived mesenchymal stem cells could not differentiate into sperm [34], but 
other studies confirmed the generation of germ cells in vivo in BM-MSC-transplanted 
mice [35, 36]. At the same time, in azoospermic rat model, BM-MSC allotransplanta-
tion amplified endogenous fertility recovery in both testicular torsion model and 
busulfan-induced model of azoospermia induction [26, 37–40]. The potential of 
BM-MSCs to differentiate or trans-differentiate into multi-lineage cells, secrete para-
crine factors to recruit the resident stem cells to participate in tissue regeneration, or 
fuse with the local cells in the affected region has been demonstrated [39].
The next group used AT-MSCs for induction of spermatogenesis. Intra-tubal 
injection of AT-MSCs in rat model of busulfan-treated azoospermia led to recovery 
of fertility [12, 32]. The last group of studies induces spermatogenesis using xeno-
transplantation of human umbilical cord MSCs in immunodeficient mice seminifer-
ous tubule [41] or a combination of in vitro differentiation of induced pluripotent 
stem cells from mice and humans into germ cells, and also their transplantation was 
performed to obtain advanced differentiated spermatozoa [42]. Interestingly, the 
capability of human umbilical cord MSCs (UC-MSCs) for differentiation into germ 
cells in the lumen of seminiferous tubules of immunocompetent mice has been 
shown [41, 43]. Furthermore, the therapeutic effects of BM-MSCs against toxic 
effects of lead (Pb) in the male gonads of rats have been shown [44].
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MSC transplantation may induce reconstitution of the tubular microenviron-
ment in azoospermic hamster which helps the remaining inactivated germinal 
cells to proliferate in the host seminiferous tubules. Sertoli cells play a major role in 
cooperation with seminiferous tubules, providing cyclic and dynamic regulation of 
spermatogenesis. In recent time, it has been demonstrated that in in vitro co-culture 
system, there is an availability of Sertoli cells to mediate differentiation of male 
germ cell-like cells, which were derived from human umbilical cord mesenchymal 
stem cells [45]. Moreover, Sertoli cells are considered as immune tolerant cells [46], 
and they can cause protection and survival of the allotransplanted donor AT-MSCs 
against inflammatory or immune reaction. In contrast, the hypoimmunogenic char-
acter of mesenchymal stem cells makes them appropriate for allogenic transplanta-
tion [47]. Nevertheless, mesenchymal stem cells generate immunosuppression or 
immunosurveillance upon transplantation [48]. It is interesting to mention that, 
related to the treatment of azoospermia, IV allogenic bone marrow-derived mes-
enchymal stem cell transfusion encourages the production of antisperm antibody 
modulated by immune system, after testis rupture in mice [49], which illustrates the 
other therapeutic potential of mesenchymal stem cells in the treatment of infertil-
ity. In fact, the possible mechanisms of azoospermia healing by mesenchymal stem 
cells are unclear; three main mechanisms could be responsible for the recovering of 
testicular function during the tissue regeneration process period by mesenchymal 
stem cells. The first option of mesenchymal stem cells differentiation into the 
spermatozoa via appropriate induction conditions as it has been demonstrated in 
rats models [32]. Another mechanism which is not confirmed yet is that secretion of 
growth factors by mesenchymal stem cells stimulates the restoration of spermato-
genesis in the inactivated spermatogonia stem cells or Sertoli cells. And the last one 
is that mesenchymal stem cells merged with the endogenous spermatogonia stem 
cells recover the spermatogenesis, which is also needed to be further studied deeply.
The necessity for consideration of another point in cell therapy of azoospermia 
was illustrated by histomorphometric analysis of the treated seminiferous tubules 
[31]. The increase of the area of the seminiferous tubules before transplantation 
caused the decline of the number of tubes per unit area in azoospermia. This patho-
logical condition may be created due to decrease of cellular layers which caused the 
reduction of the tubal structure and collapsing of several tubules under the pressure 
of intratubular hydrostatic pressure of hamster seminiferous tubules. The growth 
of the amount of the spaces in testis may result in rise of the other tubes’ diameter 
and also decrease in intratubular hydrostatic pressure. It is necessary to mention 
that the role of this pressure in the mechanism of spermatogenesis has not been 
clarified, but it could be the one reason for the increase of diameter of cellular layer 
in mesenchymal stem cell-treated tubes. Next, histomorphometric analysis with the 
increase of the number of tubules per unit area in mesenchymal stem cells treated 
tubes has been obtained [31]. This alteration may be caused by the decline of the 
volumes of intertubular spaces or by the busulfan therapy complications. Moreover, 
the increase of the whole area of tubes during azoospermia induction could reduce 
the ability of contraction of contractile myofibroblast cells, in which the decrease 
of intratubular hydrostatic pressure in peritubular layer probably resulted in the 
reduction of spermatozoa concentration in epididymis after mesenchymal stem cell 
therapy.
3. Conclusion
The obtained results of performed research trials on animal models provide 
a better and deeper overview of MSC therapy in male infertility conditions. The 
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demonstrated results of used options in the treatment of these conditions revealed 
that methods using the MSCs derived from umbilical cord, adipose tissue, and the 
bone marrow appear more appropriate to recover the fertility due to better results. 
Although a case report is available for treatment of azoospermia in man [50], 
applying those methods into the human practice seems to be investigated before 
introducing this method into clinic.
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